FIL Limited reports 8.7% stake in Zepp Health

FIL Limited and related entities have disclosed a significant stake in Zepp Health Corp. As of 12/31/2025, they report beneficial ownership of 10,012,096 Class A common shares, representing 8.7% of the class.

Rhea-AI Filing Summary

FIL Limited and related entities have disclosed a significant stake in Zepp Health Corp. As of 12/31/2025, they report beneficial ownership of 10,012,096 Class A common shares, representing 8.7% of the class. These shares are held with sole power to dispose but no shared voting or dispositive power.

The filing notes that one or more other persons have rights to dividends or sale proceeds, including Fidelity Funds - China Focus, whose interest was 5,998,048 Class A shares, or 5.2% of the outstanding class as of 12/31/2025. The securities are stated as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Zepp Health.

Insights

Equity ownership & governance analyst

Zepp Health gains a disclosed 8.7% institutional holder, filed as passive.

FIL Limited and affiliated entities report beneficial ownership of 10,012,096 Zepp Health Class A shares, or 8.7%, as of 12/31/2025. They report sole dispositive power over these shares and characterize the position as held in the ordinary course of business.

The filing also highlights that Fidelity Funds - China Focus holds 5,998,048 shares, or 5.2% of the outstanding Class A shares as of 12/31/2025, with rights to dividends or sale proceeds. This indicates Zepp has at least two sizable institutional positions in its Class A stock.

The certification that the stake is not held for the purpose of changing or influencing control aligns with a passive investment stance typical of a Schedule 13G. Future ownership updates in subsequent beneficial ownership filings will show whether this position grows, shrinks, or remains relatively stable over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Zepp Health (ZEPP) shares does FIL Limited beneficially own?

FIL Limited reports beneficial ownership of 10,012,096 Zepp Health Class A common shares. This represents 8.7% of the outstanding Class A stock as of December 31, 2025, with sole dispositive power and no shared voting or dispositive authority disclosed.

What percentage of Zepp Health’s Class A stock is held by FIL Limited?

FIL Limited and related entities report holding 8.7% of Zepp Health’s Class A common stock. This stake equals 10,012,096 shares, based on outstanding share figures as of December 31, 2025, and is reported as a position held in the ordinary course of business.

Which other investor in Zepp Health (ZEPP) is highlighted in this Schedule 13G?

The filing highlights Fidelity Funds - China Focus as another key holder. Its interest in Zepp Health’s Class A common stock was 5,998,048 shares, or 5.2% of the outstanding class, as of December 31, 2025, with rights to dividends or sale proceeds.

Is FIL Limited’s Zepp Health stake reported as a passive investment?

Yes. FIL Limited certifies the Zepp Health securities were acquired and are held in the ordinary course of business. The filing states they are not held for the purpose of changing or influencing control of Zepp Health or in connection with any such control transaction.

Who are the reporting persons in the Zepp Health (ZEPP) Schedule 13G filing?

The reporting persons are FIL Limited, Pandanus Partners, L.P., and Pandanus Associates, Inc. Each reports beneficial ownership of 10,012,096 Zepp Health Class A shares, equal to 8.7% of the class, with disclosures about sole dispositive power over these securities.

What is the reference date for ownership levels in this Zepp Health Schedule 13G?

The ownership levels are stated as of December 31, 2025. On that date, FIL Limited and related entities reported 10,012,096 Zepp Health Class A shares (8.7%), and Fidelity Funds - China Focus reported 5,998,048 shares (5.2%) of the total outstanding Class A stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/05/2026 - 01:08 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ZEPP HEALTH CORP

(Name of Issuer)

CLASS A COMMON STOCK

(Title of Class of Securities)

98945L204

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 98945L204

1

Names of Reporting Persons

FIL Limited

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

BERMUDA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 10,012,096.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 10,012,096.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,012,096.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.7 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

CUSIP No. 98945L204

1

Names of Reporting Persons

Pandanus Partners, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 10,012,096.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,012,096.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.7 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 98945L204

1

Names of Reporting Persons

Pandanus Associates, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 10,012,096.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

10,012,096.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.7 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ZEPP HEALTH CORP
(b)	Address of issuer's principal executive offices: BUILDING B2, ZHONG'AN CHUANGGU,TECHNOLOGY PARK NO.900 WANGJIANG WEST RD,HEFEI,F4,230088
Item 2.
(a)	Name of person filing: FIL Limited
(b)	Address or principal business office or, if none, residence: Pembroke Hall, 42 Crow Lane, Hamilton, Bermuda, HM19
(c)	Citizenship: Not applicable
(d)	Title of class of securities: CLASS A COMMON STOCK
(e)	CUSIP No.: 98945L204
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	Please see Exhibit 99.
Item 4.	Ownership
(a)	Amount beneficially owned: 10012096.00
(b)	Percent of class: 8.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page.
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 10012096.00
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of ZEPP HEALTH CORP. The interest of Fidelity Funds - China Focus, in the CLASS A COMMON STOCK of ZEPP HEALTH CORP, amounted to 5998048.00 shares or 5.2% of the total outstanding CLASS A COMMON STOCK at 12/31/2025.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See attached Exhibit 99.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FIL Limited

Signature:	Stephanie J. Brown
Name/Title:	Duly authorized under Power of Attorney effective as of December 19, 2022, by and on behalf of FIL Limited and its direct and indirect subsidiaries*
Date:	02/04/2026

Pandanus Partners, L.P.

Signature:	Stephanie J. Brown
Name/Title:	Duly authorized under Power of Attorney effective as of December 19, 2022, by Pandanus Associates, Inc. on behalf of Pandanus Partners, L.P.*
Date:	02/04/2026

Pandanus Associates, Inc.

Signature:	Stephanie J. Brown
Name/Title:	Duly authorized under Power of Attorney effective as of December 19, 2022, by and on behalf of Pandanus Associates, Inc.*
Date:	02/04/2026

Comments accompanying signature: This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FIL Limited on January 31, 2023, accession number: 0000318989-23-000005.

Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.